Does RISANKIZUMAB Cause Off label use? 100 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 100 reports of Off label use have been filed in association with RISANKIZUMAB (Skyrizi). This represents 3.8% of all adverse event reports for RISANKIZUMAB.
100
Reports of Off label use with RISANKIZUMAB
3.8%
of all RISANKIZUMAB reports
1
Deaths
9
Hospitalizations
How Dangerous Is Off label use From RISANKIZUMAB?
Of the 100 reports, 1 (1.0%) resulted in death, 9 (9.0%) required hospitalization, and 1 (1.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB. However, 100 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB Cause?
Product storage error (396)
Drug ineffective (206)
Psoriasis (138)
Crohn's disease (103)
Arthralgia (100)
Product temperature excursion issue (88)
Diarrhoea (72)
Fatigue (70)
Rash (64)
Pruritus (61)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which RISANKIZUMAB Alternatives Have Lower Off label use Risk?
RISANKIZUMAB vs RISANKIZUMAB-RZAA
RISANKIZUMAB vs RISDIPLAM
RISANKIZUMAB vs RISEDRONATE
RISANKIZUMAB vs RISEDRONIC ACID
RISANKIZUMAB vs RISPERDAL